Kisojibiotech
1 known investors
KisoJi Biotechnology discovers and develops antibody therapeutics targeting oncology and other diseases using a proprietary platform based on single domain antibodies and AI-enabled fingerprinting technology. The company enables creation of multi-specific antibodies designed for therapeutic, diagnostic, and vaccine applications.
AI & Machine LearningBiotechMedical Devices